C2i Genomics and Karkinos Healthcare partner to bring AI-powered cancer detection and monitoring to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
Investment with representation on the Board of Directors and technical know-how
Revolutionary ovarian cancer rapid test available Q4 2022
CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng
RNAstorm and DNAstorm RNA/DNA extraction kits will be sold exclusively through the Biotium website and authorized distributors
At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes
The main aim of the challenge is to encourage early-stage start-ups and individuals working on innovations in Ayurveda and other alternative healing and medicine systems
Exclusive distribution agreement brings Point-Of-Care (POC) haematology diagnostics to new regions in the Middle East
India accounts for more than half (almost 60%) of new leprosy cases worldwide, despite being declared ‘leprosy-free’ in 2005.
Subscribe To Our Newsletter & Stay Updated